Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...

Patients can benefit both financially and clinically by enrolling in ongoing clinical trials, said Eric Lander, MD.

Widespread noncompliance with federal cost-sharing rules exists, particularly impacting Medicare beneficiaries and ...

FDA approves Monjuvi (tafasitamab) for relapsed follicular lymphoma, offering hope with improved progression-free survival in ...

In this interview with TRUST-I and TRUST-II trial investigator, Jorge J. Nieva, MD, USC Keck School of Medicine, he walks through the design of the trials, the results that supported the FDA approval, ...

For patients with obesity, clinicians should move beyond a "try and fail" approach to lifestyle interventions and prioritize ...

It's a critical time to spotlight the dire health disparities affecting Black Americans, from premature deaths to maternal ...

Dupilumab was approved by the FDA to treat bullous pemphigoid, that demonstrated its efficacy in achieving sustained disease ...

Patients were stratified into 4 risk groups based on recent heart failure hospitalization (HFH) and use of loop diuretics. 1 ...

The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across ...

The recent FDA approval of lenacapavir is encouraging in its promise of long-term HIV prevention but might not be available for the vast majority of people in the US.

Making clinical trials easier to find for clinicians and making protocols for entering clinical trials more lenient can help ...